Chronic heart failure in adults: diagnosis and management

before and after each dose increment. [2025] 1.7.8 For people with symptoms of postural hypotension, measure blood pressure according to recommendation 1.1.5 in NICE's guideline on hypertension in adults. [2025] For a short explanation of why the committee made the 2025 recommendations and how they might affect practice, see the rationale and impact section on starting and monitoring medicine use. Full details of the evidence and the committee's discussion are in the evidence reviews A: medicines for heart failure with reduced ejection fraction, B: medicines for heart failure with mildly reduced ejection fraction and D: MRA for heart failure with preserved ejection fraction. Beta-blockers 1.7.9 Do not withhold treatment with a beta-blocker solely because of age or the presence of peripheral vascular disease, erectile dysfunction, diabetes, interstitial pulmonary disease or chronic obstructive pulmonary disease. [2010] 1.7.10 Assess for heart rhythm, heart rate and conduction abnormalities using a 12-lead ECG before deciding whether to prescribe a beta-blocker. [2025] 1.7.11 Do not offer a beta-blocker to people with second-degree or third-degree heart block who do not have a pacemaker or to people with bradycardia (that is, a heart rate of less than 50 beats per minute). [2025] 1.7.12 Assess heart rate and
